USA |NASDAQ |USD
| Report Date | Period Ending | EPS Forecast | Last Quarter's EPS | Last Year's EPS |
|---|---|---|---|---|
| Nov 8, 2021 | Sep 2021 | $-0.48 | $-0.56 | $-0.35 |
| Report Date | Period Ending | Revenue Forecast | Last Quarter’s Revenue | Last Year’s Revenue |
|---|---|---|---|---|
| Nov 8, 2021 | Sep 2021 | $10.98M | $1.81M | $5.03M |
Chemocentryx, Inc's next earnings date is Monday, Nov 8, 2021 for the fiscal quarter ending Sep 2021.
| Period End | # of Analysts | EPS Forecast | Low EPS Forecast | High EPS Forecast |
|---|---|---|---|---|
| Dec 2021 | 8 | $-0.33 | $-0.72 | $0.03 |
| Period End | # of Analysts | EPS Forecast | Low EPS Forecast | High EPS Forecast |
|---|---|---|---|---|
| Dec 2021 | 8 | $-1.80 | $-2.31 | $-1.28 |
| Dec 2022 | 8 | $-1.98 | $-2.71 | $-1.34 |
| Period End | Up/Down 1M | 1M Trend | 2M Trend | 3M Trend |
|---|---|---|---|---|
| Dec 2021 | 4 / 3 | $-0.48 | $-0.49 | $-0.49 |
| Period End | Up/Down 1M | 1M Trend | 2M Trend | 3M Trend |
|---|---|---|---|---|
| Dec 2021 | 4 / 3 | $-1.96 | $-1.99 | $-1.98 |
| Dec 2022 | 4 / 3 | $-2.15 | $-2.01 | $-1.85 |
| Period End | # of Analysts | Revenue Forecast | Low Revenue Forecast | High Revenue Forecast |
|---|---|---|---|---|
| Dec 2021 | 8 | $25.83M | $5.47M | $48.19M |
| Period End | # of Analysts | EPS Forecast | Low EPS Forecast | High EPS Forecast |
|---|---|---|---|---|
| Dec 2021 | 8 | $48.94M | $20.09M | $82.36M |
| Dec 2022 | 8 | $90.31M | $52.56M | $118.30M |
| Report Date | Period Ending | Forecast EPS | Actual EPS | Surprise |
|---|---|---|---|---|
| Nov 8, 2021 | Sep 2021 | $-0.48 | - | - |
| Aug 9, 2021 | Jun 2021 | $-0.54 | $-0.56 | -2.96% |
| Apr 29, 2021 | Mar 2021 | $-0.42 | $-0.43 | -2.50% |
| Mar 1, 2021 | Dec 2020 | $-0.33 | $-0.43 | -29.56% |
| Nov 9, 2020 | Sep 2020 | $-0.36 | $-0.35 | 1.60% |
| Aug 10, 2020 | Jun 2020 | $-0.34 | $0.29 | 186.13% |
| May 11, 2020 | Mar 2020 | $-0.30 | $-0.35 | -17.65% |
| Mar 10, 2020 | Dec 2019 | $-0.25 | $-0.26 | -4.42% |
| Nov 4, 2019 | Sep 2019 | $-0.26 | $-0.22 | 16.09% |
| Aug 5, 2019 | Jun 2019 | $-0.22 | $-0.26 | -17.12% |
| May 6, 2019 | Mar 2019 | $-0.26 | $-0.23 | 10.26% |
| Mar 11, 2019 | Dec 2018 | $-0.27 | $-0.21 | 21.58% |
| Nov 8, 2018 | Sep 2018 | $-0.25 | $-0.22 | 10.31% |
| Aug 9, 2018 | Jun 2018 | $-0.23 | $-0.14 | 39.89% |
| May 9, 2018 | Mar 2018 | $-0.24 | $-0.19 | 22.19% |
| Mar 9, 2018 | Dec 2017 | $-0.18 | $0.80 | 554.03% |
| Nov 7, 2017 | Sep 2017 | $-0.32 | $-0.13 | 58.76% |
| Aug 8, 2017 | Jun 2017 | $-0.17 | $-0.19 | -11.76% |
| May 10, 2017 | Mar 2017 | $-0.30 | $-0.12 | 60.00% |
| Mar 14, 2017 | Dec 2016 | $-0.22 | $-0.16 | 27.27% |
| Nov 7, 2016 | Sep 2016 | $-0.08 | $-0.15 | -87.50% |
| Aug 8, 2016 | Jun 2016 | $0.07 | $-0.22 | -414.29% |
| May 10, 2016 | Mar 2016 | $-0.27 | $-0.34 | -25.93% |
| Mar 14, 2016 | Dec 2015 | $-0.28 | $-0.26 | 8.58% |
| Nov 9, 2015 | Sep 2015 | $-0.28 | $-0.26 | 7.14% |
| Aug 6, 2015 | Jun 2015 | $-0.28 | $-0.28 | - |
| May 6, 2015 | Mar 2015 | $-0.28 | $-0.28 | - |
| Mar 12, 2015 | Dec 2014 | $-0.28 | $-0.28 | - |
| Nov 5, 2014 | Sep 2014 | $-0.28 | $-0.25 | 10.71% |
| Aug 5, 2014 | Jun 2014 | $-0.26 | $-0.28 | -7.69% |
| May 8, 2014 | Mar 2014 | $-0.24 | $-0.27 | -12.50% |
| Mar 13, 2014 | Dec 2013 | $-0.24 | $-0.22 | 8.33% |
| Nov 7, 2013 | Sep 2013 | $-0.26 | $-0.22 | 15.38% |
| Aug 12, 2013 | Jun 2013 | $-0.28 | $-0.23 | 17.86% |
| May 13, 2013 | Mar 2013 | $-0.26 | $-0.28 | -7.69% |
| Mar 13, 2013 | Dec 2012 | $-0.28 | $-0.28 | - |
| Nov 13, 2012 | Sep 2012 | $-0.22 | $-0.28 | -27.27% |
| Aug 10, 2012 | Jun 2012 | $-0.21 | $-0.30 | -42.86% |
| May 10, 2012 | Mar 2012 | $-0.21 | $-0.28 | -33.33% |
| Mar 30, 2012 | Dec 2011 | - | $4.33 | - |
| Report Date | Period Ending | Forecast EPS | Actual EPS | Surprise |
|---|---|---|---|---|
| Mar 1, 2021 | Dec 2020 | $-0.74 | $-0.84 | - |
| Mar 10, 2020 | Dec 2019 | $-0.97 | $-0.97 | - |
| Mar 11, 2019 | Dec 2018 | $-0.83 | $-0.76 | - |
| Mar 9, 2018 | Dec 2017 | $-0.65 | $0.36 | - |
| Mar 14, 2017 | Dec 2016 | - | $-0.87 | - |
| Mar 14, 2016 | Dec 2015 | - | $-1.08 | - |
| Mar 12, 2015 | Dec 2014 | - | $-1.08 | - |
| Mar 13, 2014 | Dec 2013 | - | $-0.95 | - |
| Mar 13, 2013 | Dec 2012 | - | $-1.14 | - |
| Mar 30, 2012 | Dec 2011 | - | $4.33 | - |
| Report Date | Period Ending | Forecast Revenue | Actual Revenue | Surprise |
|---|---|---|---|---|
| Nov 8, 2021 | Sep 2021 | $10.98M | - | - |
| Aug 9, 2021 | Jun 2021 | $1.81M | $1.81M | 1.00% |
| Apr 29, 2021 | Mar 2021 | $7.93M | $10.22M | 1.29% |
| Mar 1, 2021 | Dec 2020 | $7.99M | $4.36M | 0.55% |
| Nov 9, 2020 | Sep 2020 | $10.70M | $5.03M | 0.47% |
| Aug 10, 2020 | Jun 2020 | $8.25M | $49.28M | 5.97% |
| May 11, 2020 | Mar 2020 | $8.75M | $5.86M | 0.67% |
| Mar 10, 2020 | Dec 2019 | $9.68M | $9.87M | 1.02% |
| Nov 4, 2019 | Sep 2019 | $7.70M | $10.58M | 1.37% |
| Aug 5, 2019 | Jun 2019 | $9.83M | $7.17M | 0.73% |
| May 6, 2019 | Mar 2019 | $10.97M | $8.33M | 0.76% |
| Mar 11, 2019 | Dec 2018 | $9.41M | $9.33M | 0.99% |
| Nov 8, 2018 | Sep 2018 | $8.97M | $8.97M | 1.00% |
| Aug 9, 2018 | Jun 2018 | $14.06M | $15.02M | 1.07% |
| May 9, 2018 | Mar 2018 | $6.30M | $9.55M | 1.52% |
| Mar 9, 2018 | Dec 2017 | $9.40M | $56.30M | 5.99% |
| Nov 7, 2017 | Sep 2017 | $9.03M | $9.03M | 1.00% |
| Aug 8, 2017 | Jun 2017 | $8.94M | $8.94M | 1.00% |
| May 10, 2017 | Mar 2017 | - | $8.23M | - |
| Mar 14, 2017 | Dec 2016 | - | $4.68M | - |
| Nov 7, 2016 | Sep 2016 | - | $4.13M | - |
| Aug 8, 2016 | Jun 2016 | - | $2.62M | - |
| May 10, 2016 | Mar 2016 | - | $0.00 | - |
| Mar 14, 2016 | Dec 2015 | - | $0.00 | - |
| Nov 9, 2015 | Sep 2015 | - | $0.00 | - |
| Aug 6, 2015 | Jun 2015 | - | $0.00 | - |
| May 6, 2015 | Mar 2015 | - | $0.00 | - |
| Mar 12, 2015 | Dec 2014 | - | $0.00 | - |
| Nov 5, 2014 | Sep 2014 | - | $0.00 | - |
| Aug 5, 2014 | Jun 2014 | - | $0.00 | - |
| May 8, 2014 | Mar 2014 | - | $725.00K | - |
| Mar 13, 2014 | Dec 2013 | - | $725.00K | - |
| Nov 7, 2013 | Sep 2013 | - | $1.52M | - |
| Aug 12, 2013 | Jun 2013 | - | $1.89M | - |
| May 13, 2013 | Mar 2013 | - | $1.93M | - |
| Mar 13, 2013 | Dec 2012 | - | $2.15M | - |
| Nov 13, 2012 | Sep 2012 | - | $1.13M | - |
| Aug 10, 2012 | Jun 2012 | - | $1.13M | - |
| May 10, 2012 | Mar 2012 | - | $1.02M | - |
| Mar 30, 2012 | Dec 2011 | - | $26.05M | - |
| Report Date | Period Ending | Forecast Revenue | Actual Revenue | Surprise |
|---|---|---|---|---|
| Mar 1, 2021 | Dec 2020 | $68.44M | $64.89M | -5.19% |
| Mar 10, 2020 | Dec 2019 | $35.74M | $35.95M | 0.59% |
| Mar 11, 2019 | Dec 2018 | $43.06M | $42.88M | -0.43% |
| Mar 9, 2018 | Dec 2017 | $35.53M | $82.50M | 132.19% |
| Mar 14, 2017 | Dec 2016 | - | $11.44M | - |
| Mar 14, 2016 | Dec 2015 | - | $0.00 | - |
| Mar 12, 2015 | Dec 2014 | - | $0.00 | - |
| Mar 13, 2014 | Dec 2013 | - | $6.06M | - |
| Mar 13, 2013 | Dec 2012 | - | $5.42M | - |
| Mar 30, 2012 | Dec 2011 | - | $31.67M | - |
CCXI's next earnings date is Monday, Nov 8, 2021 for the fiscal quarter ending Sep 30, 2021.
According to 8 analysts, the average EPS estimation for Chemocentryx, Inc's next quarterly earnings is $-0.48, with a low EPS estimation of $-0.68, and a high estimation of $-0.31.
Over the last 1 month, EPS estimates have seen 2 upward revisions and 2 downward. The EPS 1 month trend is $-0.49, the last 2 month trend is $-0.50, and the 3 month trend is $-0.52.
Based on 8 analysts, the average revenue estimation is $10.98M, with a low revenue estimation of $2.50M, and a high estimation of $22.00M.
Chemocentryx, Inc's previous earnings date was Aug 9, 2021 for its fiscal quarter ended Jun 30, 2021.
CCXI's earnings per share (EPS) was $-0.56, missing the consensus analysts forecast of $-0.54 by -2.96%.
The EPS was lower than the previous fiscal quarter (Mar 2021) by 30.23%, and lower than the same period a year before (Jun 2020) by -293.10%.
Revenues were $1.81M, better than the forecast of $1.81M by 0.00%, down by -82.27% from the previous quarter , and down by -96.32% from the same period last year.
The company reported a net income of $-39.21M.Free cash flow for the quarter was $-53.59M , compared to $-32.45M last quarter and $-19.58M a year before.
CCXI ended the quarter with $26.53M in total debt, an increase of 2.33% compared to the previous quarter, and a decrease of -86.44% compared to the same quarter a year before.
Chemocentryx, Inc's previous annual earnings date was Mar 1, 2021 for its fiscal year ended Dec 31, 2020.
CCXI's earnings per share (EPS) was $-0.84, missing the consensus analysts forecast of $-0.74 by 13.51% , and higher than the previous year's EPS (Dec 2019) by -13.40%.
Revenues were $64.89M, worse than the forecast of $68.44M by -5.19%, and up by 80.49% from previous year's revenue.
The company reported a net income of $-55.36M.
Chemocentryx, Inc reported a free cash flow of $-96.55M for its fiscal year, compared to $-70.91M a year ago.
The company ended the fiscal year with $25.25M in total debt, an increase of 18.59% compared to the previous year.
Get a weekly snapshot of one new investment idea from stock exchanges worldwide.
